[BOOK][B] Basics Hämatologie

M Michl - 2023 - books.google.com
Das BASICS Hämatologie bringt Ihnen den perfekten Überblick über die gesamte
Bandbreite der Hämatologie. GUT: umfassender Einblick über die gesamte Bandbreite der …

[HTML][HTML] Early tumour shrinkage (ETS) and depth of response (DpR) in the treatment of patients with metastatic colorectal cancer (mCRC)

…, DP Modest, C Giessen-Jung, M Michl… - European journal of …, 2015 - Elsevier
Background Response evaluation criteria in solid tumours (RECIST) are used to define
degrees of response to anti-tumour agents. In retrospective analyses, early tumour shrinkage (…

[HTML][HTML] Treatment of advanced gastrointestinal tumors with genetically modified autologous mesenchymal stromal cells (TREAT-ME1): study protocol of a phase I/II …

H Niess, JC von Einem, MN Thomas, M Michl… - BMC cancer, 2015 - Springer
Background Adenocarcinoma originating from the digestive system is a major contributor to
cancer-related deaths worldwide. Tumor recurrence, advanced local growth and metastasis …

18F-FDG PET/CT predicts survival after radioembolization of hepatic metastases from breast cancer

…, C Trumm, CJ Zech, M Michl… - Journal of Nuclear …, 2012 - Soc Nuclear Med
90 Y radioembolization (selective internal radiation therapy [SIRT]) has emerged as a
valuable therapeutic option in unresectable, chemotherapy-refractory hepatic metastases from …

Pattern and dynamics of distant metastases in metastatic colorectal cancer

JW Holch, M Demmer, C Lamersdorf, M Michl… - Visceral …, 2017 - karger.com
Background: Few studies report the incidence of metastatic patterns in colorectal cancer.
Furthermore, little is known about dynamic aspects of these metastases during the course of …

Isolated pulmonary metastases define a favorable subgroup in metastatic pancreatic cancer

…, S Ormanns, DP Modest, CB Westphalen, M Michl… - Pancreatology, 2016 - Elsevier
Purpose Liver metastasis represents the first site of dissemination in >80% of metastatic
pancreatic cancer (PC) patients. Pulmonary metastasis as first site of dissemination in PC is a …

Brain metastasis in colorectal cancer patients: survival and analysis of prognostic factors

M Michl, J Thurmaier, G Schubert-Fritschle… - Clinical colorectal …, 2015 - Elsevier
Background The purpose of the study was to characterize the rare cohort of patients (pts) with
metastatic colorectal cancer (mCRC) and brain metastasis (BM) and to identify prognostic …

Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells: Results from the phase 1/2 TREAT‐ME‐1 trial

…, C Salat, O Stoetzer, PJ Nelson, M Michl… - … journal of cancer, 2019 - Wiley Online Library
Marlies Michl has no personal or financial conflict of interest within the submitted work, but
received honoraria from SIRTEX, Roche, MSD and MERCK and travel support from SIRTEX, …

Safety, efficacy, and prognostic factors after radioembolization of hepatic metastases from breast cancer: a large single-center experience in 81 patients

…, PM Paprottka, TF Jakobs, M Michl… - Journal of Nuclear …, 2016 - Soc Nuclear Med
The present study evaluated safety, efficacy, and prognostic factors for 90 Y-yttrium microsphere
radioembolization of unresectable liver metastases from breast cancer. Methods: Eighty-…

[HTML][HTML] Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells-TREAT-ME-1-a phase I, first in human, first in …

…, G Grütz, C Salat, O Stoetzer, PJ Nelson, M Michl… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Purpose This phase I, first in human, first in class clinical study aimed at evaluating the safety,
tolerability and efficacy of treatment with genetically modified mesenchymal stromal cells (…